Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 401 entries
View as:

Methionine PET/CT Studies In Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00840047 Org: User:
Start: 07/20/09 End: 07/27/27 Due: 07/27/28

St. Jude Tracking of Viral and Host Factors Associated With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04362995 Org: User:
Start: 04/23/20 End: 07/29/24 Due: 07/29/25

Study for Treatment of Cancer in Children With Ataxia-telangiectasia

Phase: N/A Priority: Normal
NCT ID: NCT00187057 Org: User:
Start: 09/30/02 End: 06/30/13 Due: 06/30/14

Reduced Intensity Transplantation for Severe Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT04362293 Org: User:
Start: 04/30/20 End: 08/01/27 Due: 08/01/28

Radiation Therapy to Treat Musculoskeletal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00186992 Org: User:
Start: 01/10/03 End: 10/31/29 Due: 10/31/30

Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance

Phase: N/A Priority: Normal
NCT ID: NCT04714840 Org: User:
Start: 02/08/21 End: 12/31/26 Due: 12/31/27

Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT00186797 Org: User:
Start: 12/31/02 End: 05/31/07 Due: 05/31/08

Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study

Phase: N/A Priority: Normal
NCT ID: NCT05128903 Org: User:
Start: 07/05/22 End: 12/31/25 Due: 12/31/26

Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort

Phase: N/A Priority: Normal
NCT ID: NCT01700959 Org: User:
Start: 02/06/13 End: 04/19/17 Due: 04/19/18

Radiofrequency Ablation of Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00705497 Org: User:
Start: 01/31/03 End: 10/31/08 Due: 10/31/09

Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT01849393 Org: User:
Start: 06/30/13 End: 12/31/13 Due: 12/31/14

Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis

Phase: N/A Priority: Normal
NCT ID: NCT04551131 Org: User:
Start: 07/13/21 End: 08/31/26 Due: 08/31/27

Needs Assessment of Knowledge, Beliefs, and Attitudes of Patients With Hemophilia B About Gene Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05044845 Org: User:
Start: 01/18/22 End: 12/31/25 Due: 12/31/26

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01946529 Org: User:
Start: 12/27/13 End: 07/31/26 Due: 07/31/27

Transcranial Photobiomodulation Treatment in Patients With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT06797583 Org: User:
Start: 05/31/25 End: 12/31/29 Due: 12/31/30

Examination of Sleep and Family Functioning in Pediatric Craniopharyngioma Patients

Phase: N/A Priority: Normal
NCT ID: NCT03330080 Org: User:
Start: 02/12/18 End: 01/29/19 Due: 01/29/20

An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04733534 Org: User:
Start: 06/06/22 End: 12/31/27 Due: 12/31/28

Haploidentical Hematopoietic Stem Cell Transplantation Patients With Wiskott-Aldrich Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00160355 Org: User:
Start: 05/31/05 End: 02/28/09 Due: 02/28/10

T-cell Responses to Concurrent HIV and Herpesvirus Infections

Phase: N/A Priority: Normal
NCT ID: NCT03996018 Org: User:
Start: 06/19/19 End: 07/28/23 Due: 07/28/24

A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection

Phase: N/A Priority: Normal
NCT ID: NCT02792582 Org: User:
Start: 06/22/16 End: 12/31/28 Due: 12/31/29

Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04023669 Org: User:
Start: 08/08/19 End: 01/13/25 Due: 01/13/26

Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00187174 Org: User:
Start: 10/31/04 End: 10/31/08 Due: 10/31/09

A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00187031 Org: User:
Start: 11/30/02 End: 10/31/07 Due: 10/31/08

A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00756340 Org: User:
Start: 07/31/08 End: 09/30/15 Due: 09/30/16

Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00124657 Org: User:
Start: 03/31/05 End: 09/30/14 Due: 09/30/15